Site-specific protein O-glycosylation modulates proprotein processing - Deciphering specific functions of the large polypeptide GalNAc-transferase gene family

Biochimica et Biophysica Acta - General Subjects

Volumn 1820, Issue 12, 2012, Pages 2079-2094

  Schjoldager, Katrine T B G ^a   Clausen, Henrik ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Congenital disorder of glycosylation (CDG); GalNAc transferase (UDP GalNAc:polypeptide N acetylgalactosaminyltransferase); O glycosylation; Pro protein convertase (PC) processing; Zinc finger nuclease gene targeting

Indexed keywords

ADAM PROTEIN; FIBROBLAST GROWTH FACTOR 23; GLYCOPROTEIN; GLYCOPROTEOME; ISOENZYME; N ACETYLGALACTOSAMINYLTRANSFERASE; POLYPEPTIDE; PROTEINASE; PROTEOME; REGULATOR PROTEIN; SERINE PROTEINASE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CELL SPECIFICITY; ENZYME SPECIFICITY; GALNAC TRANSFERASE GENE; GALNT3 GENE; GENE; GENE FUNCTION; GENE INACTIVATION; GENE TARGETING; GENETIC DISORDER; HUMAN; MULTIGENE FAMILY; NONHUMAN; PATHOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN GLYCOSYLATION; PROTEIN MOTIF; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; TISSUE SPECIFICITY; ZINC FINGER NUCLEASE GENE;

AMINO ACID SEQUENCE; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; N-ACETYLGALACTOSAMINYLTRANSFERASES; PROPROTEIN CONVERTASES; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84867426941     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2012.09.014     Document Type: Review

References (213)

1. K. Ohtsubo, and J.D. Marth Glycosylation in cellular mechanisms of health and disease Cell 126 2006 855 867
2. C.J. Vidal Post-translational Modifications in Health and Disease 2011 Springer New York
3. R. Apweiler, H. Hermjakob, and N. Sharon On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database Biochim. Biophys. Acta 1473 1999 4 8
4. R. Kornfeld, and S. Kornfeld Assembly of asparagine-linked oligosaccharides Annu. Rev. Biochem. 54 1985 631 664
5. P. Stanley Golgi glycosylation Cold Spring Harb. Perspect. Biol. 3 2011
6. A. Halim, G. Brinkmalm, U. Ruetschi, A. Westman-Brinkmalm, E. Portelius, H. Zetterberg, K. Blennow, G. Larson, and J. Nilsson Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein/amyloid beta-peptides in human cerebrospinal fluid Proc. Natl. Acad. Sci. U.S.A. 108 2011 11848 11853
7. C. Steentoft, S.Y. Vakhrushev, M.B. Vester-Christensen, K.T. Schjoldager, Y. Kong, E.P. Bennett, U. Mandel, H. Wandall, S.B. Levery, and H. Clausen Mining the O-glycoproteome using zinc-finger nuclease-glycoengineered SimpleCell lines Nat. Methods 8 2011 977 982
8. R.G. Spiro Characterization and quantitative determination of the hydroxylysine-linked carbohydrate units of several collagens J. Biol. Chem. 244 1969 602 612
9. F.G. Hanisch O-glycosylation of the mucin type Biol. Chem. 382 2001 143 149
10. N.R. Smalheiser, S.M. Haslam, M. Sutton-Smith, H.R. Morris, and A. Dell Structural analysis of sequences O-linked to mannose reveals a novel Lewis X structure in cranin (dystroglycan) purified from sheep brain J. Biol. Chem. 273 1998 23698 23703
11. H. Nishimura, S. Kawabata, W. Kisiel, S. Hase, T. Ikenaka, T. Takao, Y. Shimonishi, and S. Iwanaga Identification of a disaccharide (Xyl-Glc) and a trisaccharide (Xyl2-Glc) O-glycosidically linked to a serine residue in the first epidermal growth factor-like domain of human factors VII and IX and protein Z and bovine protein Z J. Biol. Chem. 264 1989 20320 20325
12. R.J. Harris, and M.W. Spellman O-linked fucose and other post-translational modifications unique to EGF modules Glycobiology 3 1993 219 224
13. S. Bjoern, D.C. Foster, L. Thim, F.C. Wiberg, M. Christensen, Y. Komiyama, A.H. Pedersen, and W. Kisiel Human plasma and recombinant factor VII. Characterization of O-glycosylations at serine residues 52 and 60 and effects of site-directed mutagenesis of serine 52 to alanine J. Biol. Chem. 266 1991 11051 11057
14. G.D. Holt, R.S. Haltiwanger, C.R. Torres, and G.W. Hart Erythrocytes contain cytoplasmic glycoproteins. O-linked GlcNAc on band 4.1 J. Biol. Chem. 262 1987 14847 14850
15. A. Matsuura, M. Ito, Y. Sakaidani, T. Kondo, K. Murakami, K. Furukawa, D. Nadano, T. Matsuda, and T. Okajima O-linked N-acetylglucosamine is present on the extracellular domain of notch receptors J. Biol. Chem. 283 2008 35486 35495
16. Y. Sakaidani, N. Ichiyanagi, C. Saito, T. Nomura, M. Ito, Y. Nishio, D. Nadano, T. Matsuda, K. Furukawa, and T. Okajima O-linked-N-acetylglucosamine modification of mammalian Notch receptors by an atypical O-GlcNAc transferase Eogt1 Biochem. Biophys. Res. Commun. 419 2012 14 19
17. Y. Sakaidani, T. Nomura, A. Matsuura, M. Ito, E. Suzuki, K. Murakami, D. Nadano, T. Matsuda, K. Furukawa, and T. Okajima O-linked-N-acetylglucosamine on extracellular protein domains mediates epithelial cell-matrix interactions Nat. Commun. 2 2011 583
18. E.P. Bennett, U. Mandel, H. Clausen, T.A. Gerken, T.A. Fritz, and L.A. Tabak Control of mucin-type O-glycosylation - a classification of the polypeptide GalNAc-transferase gene family Glycobiology 22 6 Jun. 2012 736 756
19. F.K. Hagen, K.G. Ten Hagen, T.M. Beres, M.M. Balys, B.C. VanWuyckhuyse, and L.A. Tabak cDNA cloning and expression of a novel UDP-N-acetyl-d- galactosamine:polypeptide N-acetylgalactosaminyltransferase J. Biol. Chem. 272 1997 13843 13848
20. H.H. Wandall, H. Hassan, E. Mirgorodskaya, A.K. Kristensen, P. Roepstorff, E.P. Bennett, P.A. Nielsen, M.A. Hollingsworth, J. Burchell, J. Taylor-Papadimitriou, and H. Clausen Substrate specificities of three members of the human UDP-N-acetyl-alpha-d-galactosamine:polypeptide N- acetylgalactosaminyltransferase family, GalNAc-T1, -T2, and -T3 J. Biol. Chem. 272 1997 23503 23514
21. K.G. Ten Hagen, F.K. Hagen, M.M. Balys, T.M. Beres, B. Van Wuyckhuyse, and L.A. Tabak Cloning and expression of a novel, tissue specifically expressed member of the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase family J. Biol. Chem. 273 1998 27749 27754
22. E.P. Bennett, H. Hassan, M.A. Hollingsworth, and H. Clausen A novel human UDP-N-acetyl-d-galactosamine:polypeptide N-acetylgalactosaminyltransferase, GalNAc-T7, with specificity for partial GalNAc-glycosylated acceptor substrates FEBS Lett. 460 1999 226 230
23. E.P. Bennett, H. Hassan, U. Mandel, M.A. Hollingsworth, N. Akisawa, Y. Ikematsu, G. Merkx, A.G. van Kessel, S. Olofsson, and H. Clausen Cloning and characterization of a close homologue of human UDP-N-acetyl-alpha-d- galactosamine:polypeptide N-acetylgalactosaminyltransferase-T3, designated GalNAc-T6. Evidence for genetic but not functional redundancy J. Biol. Chem. 274 1999 25362 25370
24. M.R. Pratt, H.C. Hang, K.G. Ten Hagen, J. Rarick, T.A. Gerken, L.A. Tabak, and C.R. Bertozzi Deconvoluting the functions of polypeptide N-alpha-acetylgalactosaminyltransferase family members by glycopeptide substrate profiling Chem. Biol. 11 2004 1009 1016
25. T.A. Gerken, J. Raman, T.A. Fritz, and O. Jamison Identification of common and unique peptide substrate preferences for the UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferases T1 and T2 derived from oriented random peptide substrates J. Biol. Chem. 281 2006 32403 32416
26. K.T. Schjoldager, M.B. Vester-Christensen, E.P. Bennett, S.B. Levery, T. Schwientek, W. Yin, O. Blixt, and H. Clausen O-glycosylation modulates proprotein convertase activation of angiopoietin-like protein 3: possible role of polypeptide GalNAc-transferase-2 in regulation of concentrations of plasma lipids J. Biol. Chem. 285 2010 36293 36303
27. K.T. Gram Schjoldager, M.B. Vester-Christensen, C.K. Goth, T.N. Petersen, S. Brunak, E.P. Bennett, S.B. Levery, and H. Clausen A systematic study of site-specific GalNAc-type O-glycosylation modulating proprotein convertase processing J. Biol. Chem. 286 2011 40122 40132
28. N.P. Birch, F.E. Estivariz, H.P. Bennett, and Y.P. Loh Differential glycosylation of N-POMC1-77 regulates the production of gamma 3-MSH by purified pro-opiomelanocortin converting enzyme. A possible mechanism for tissue-specific processing FEBS Lett. 290 1991 191 194
29. K.T. Schjoldager, S.Y. Vakhrushev, Y. Kong, C. Steentoft, A.S. Nudelman, N.B. Pedersen, H.H. Wandall, U. Mandel, E.P. Bennett, S.B. Levery, and H. Clausen Probing isoform-specific functions of polypeptide GalNAc-transferases using zinc finger nuclease glycoengineered SimpleCells Proc. Natl. Acad. Sci. U.S.A. 109 2012 9893 9898
30. J. Jaeken Congenital disorders of glycosylation (CDG): it's (nearly) all in it! J. Inherit. Metab. Dis. 34 2011 853 858
31. A.G. Semenov, A.B. Postnikov, N.N. Tamm, K.R. Seferian, N.S. Karpova, M.N. Bloshchitsyna, E.V. Koshkina, M.I. Krasnoselsky, D.V. Serebryanaya, and A.G. Katrukha Processing of pro-brain natriuretic peptide is suppressed by O-glycosylation in the region close to the cleavage site Clin. Chem. 55 2009 489 498
32. K. Kato, C. Jeanneau, M.A. Tarp, A. Benet-Pages, B. Lorenz-Depiereux, E.P. Bennett, U. Mandel, T.M. Strom, and H. Clausen Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation J. Biol. Chem. 281 2006 18370 18377
33. P. Van den Steen, P.M. Rudd, R.A. Dwek, and G. Opdenakker Concepts and principles of O-linked glycosylation Crit. Rev. Biochem. Mol. Biol. 33 1998 151 208
34. A. Halim, J. Nilsson, U. Ruetschi, C. Hesse, and G. Larson Human urinary glycoproteomics; attachment site specific analysis of N-and O-linked glycosylations by CID and ECD Mol. Cell Proteomics 11 4 Apr. 2012 M111.013649
35. T.A. Gerken, O. Jamison, C.L. Perrine, J.C. Collette, H. Moinova, L. Ravi, S.D. Markowitz, W. Shen, H. Patel, and L.A. Tabak Emerging paradigms for the initiation of mucin-type protein O-glycosylation by the polypeptide GalNAc transferase family of glycosyltransferases J. Biol. Chem. 286 2011 14493 14507
36. T. Sorensen, T. White, H.H. Wandall, A.K. Kristensen, P. Roepstorff, and H. Clausen UDP-N-acetyl-alpha-d-galactosamine:polypeptide N- acetylgalactosaminyltransferase. Identification and separation of two distinct transferase activities J. Biol. Chem. 270 1995 24166 24173
37. H.E. Miwa, T.A. Gerken, O. Jamison, and L.A. Tabak Isoform-specific O-glycosylation of osteopontin and bone sialoprotein by polypeptide N-acetylgalactosaminyltransferase-1 J. Biol. Chem. 285 2010 1208 1219
38. O. Topaz, D.L. Shurman, R. Bergman, M. Indelman, P. Ratajczak, M. Mizrachi, Z. Khamaysi, D. Behar, D. Petronius, V. Friedman, I. Zelikovic, S. Raimer, A. Metzker, G. Richard, and E. Sprecher Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis Nat. Genet. 36 2004 579 581
39. N.G. Seidah What lies ahead for the proprotein convertases? Ann. N. Y. Acad. Sci. 1220 2011 149 161
40. D.F. Steiner, D. Cunningham, L. Spigelman, and B. Aten Insulin biosynthesis: evidence for a precursor Science 157 1967 697 700
41. Y. Rouille, S.J. Duguay, K. Lund, M. Furuta, Q. Gong, G. Lipkind, A.A. Oliva Jr., S.J. Chan, and D.F. Steiner Proteolytic processing mechanisms in the biosynthesis of neuroendocrine peptides: the subtilisin-like proprotein convertases Front. Neuroendocrinol. 16 1995 322 361
42. K. Docherty, and J.C. Hutton Carboxypeptidase activity in the insulin secretory granule FEBS Lett. 162 1983 137 141
43. E. Bergeron, A. Basak, E. Decroly, and N.G. Seidah Processing of alpha4 integrin by the proprotein convertases: histidine at position P6 regulates cleavage Biochem. J. 373 2003 475 484
44. G. Veit, E.P. Zimina, C.W. Franzke, S. Kutsch, U. Siebolds, M.K. Gordon, L. Bruckner-Tuderman, and M. Koch Shedding of collagen XXIII is mediated by furin and depends on the plasma membrane microenvironment J. Biol. Chem. 282 2007 27424 27435
45. L. Zacchigna, C. Vecchione, A. Notte, M. Cordenonsi, S. Dupont, S. Maretto, G. Cifelli, A. Ferrari, A. Maffei, C. Fabbro, P. Braghetta, G. Marino, G. Selvetella, A. Aretini, C. Colonnese, U. Bettarini, G. Russo, S. Soligo, M. Adorno, P. Bonaldo, D. Volpin, S. Piccolo, G. Lembo, and G.M. Bressan Emilin1 links TGF-beta maturation to blood pressure homeostasis Cell 124 2006 929 942
46. X. Sun, R. Essalmani, D. Susan-Resiga, A. Prat, and N.G. Seidah Latent transforming growth factor beta-binding proteins-2 and -3 inhibit the proprotein convertase 5/6A J. Biol. Chem. 286 2011 29063 29073
47. S. Benjannet, N. Rondeau, R. Day, M. Chretien, and N.G. Seidah PC1 and PC2 are proprotein convertases capable of cleaving proopiomelanocortin at distinct pairs of basic residues Proc. Natl. Acad. Sci. U.S.A. 88 1991 3564 3568
48. W.R. Hudgins, B. Hampton, W.H. Burgess, and J.F. Perdue The identification of O-glycosylated precursors of insulin-like growth factor II J. Biol. Chem. 267 1992 8153 8160
49. S.J. Duguay, Y. Jin, J. Stein, A.N. Duguay, P. Gardner, and D.F. Steiner Post-translational processing of the insulin-like growth factor-2 precursor. Analysis of O-glycosylation and endoproteolysis J. Biol. Chem. 273 1998 18443 18451
50. J. Nilsson, U. Ruetschi, A. Halim, C. Hesse, E. Carlsohn, G. Brinkmalm, and G. Larson Enrichment of glycopeptides for glycan structure and attachment site identification Nat. Methods 6 2009 809 811
51. W.H. Daughaday, B. Trivedi, and R.C. Baxter Serum big insulin-like growth factor II from patients with tumor hypoglycemia lacks normal E-domain O-linked glycosylation, a possible determinant of normal propeptide processing Proc. Natl. Acad. Sci. U.S.A. 90 1993 5823 5827
52. N. Hizuka, I. Fukuda, K. Takano, Y. Okubo, K. Asakawa-Yasumoto, and H. Demura Serum insulin-like growth factor II in 44 patients with non-islet cell tumor hypoglycemia Endocr. J. 45 1998 S61 S65 (Suppl.)
53. C.Q. Yang, X. Zhan, X. Hu, A. Kondepudi, and J.F. Perdue The expression and characterization of human recombinant proinsulin-like growth factor II and a mutant that is defective in the O-glycosylation of its E domain Endocrinology 137 1996 2766 2773
54. U. Schellenberger, J. O'Rear, A. Guzzetta, R.A. Jue, A.A. Protter, and N.S. Pollitt The precursor to B-type natriuretic peptide is an O-linked glycoprotein Arch. Biochem. Biophys. 451 2006 160 166
55. J. Peng, J. Jiang, W. Wang, X. Qi, X.L. Sun, and Q. Wu Glycosylation and processing of pro-B-type natriuretic peptide in cardiomyocytes Biochem. Biophys. Res. Commun. 411 2011 593 598
56. S. Ichikawa, K.W. Lyles, and M.J. Econs A novel GALNT3 mutation in a pseudoautosomal dominant form of tumoral calcinosis: evidence that the disorder is autosomal recessive J. Clin. Endocrinol. Metab. 90 2005 2420 2423
57. M.F. Campagnoli, A. Pucci, E. Garelli, A. Carando, C. Defilippi, R. Lala, G. Ingrosso, I. Dianzani, M. Forni, and U. Ramenghi Familial tumoral calcinosis and testicular microlithiasis associated with a new mutation of GALNT3 in a white family J. Clin. Pathol. 59 2006 440 442
58. A.M. Barbieri, M. Filopanti, G. Bua, and P. Beck-Peccoz Two novel nonsense mutations in GALNT3 gene are responsible for familial tumoral calcinosis J. Hum. Genet. 52 2007 464 468
59. I. Chefetz, R. Heller, A. Galli-Tsinopoulou, G. Richard, B. Wollnik, M. Indelman, F. Koerber, O. Topaz, R. Bergman, E. Sprecher, and E. Schoenau A novel homozygous missense mutation in FGF23 causes familial tumoral calcinosis associated with disseminated visceral calcification Hum. Genet. 118 2005 261 266
60. C.E. Dumitrescu, M.H. Kelly, A. Khosravi, T.C. Hart, J. Brahim, K.E. White, E.G. Farrow, M.H. Nathan, M.D. Murphey, and M.T. Collins A case of familial tumoral calcinosis/hyperostosis-hyperphosphatemia syndrome due to a compound heterozygous mutation in GALNT3 demonstrating new phenotypic features Osteoporos. Int. 20 2009 1273 1278
61. Y. Frishberg, O. Topaz, R. Bergman, D. Behar, D. Fisher, D. Gordon, G. Richard, and E. Sprecher Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia syndrome and familial tumoral calcinosis are allelic disorders J. Mol. Med. 83 2005 33 38
62. H.J. Garringer, S.M. Mortazavi, F. Esteghamat, M. Malekpour, H. Boztepe, R. Tanakol, S.I. Davis, and K.E. White Two novel GALNT3 mutations in familial tumoral calcinosis Am. J. Med. Genet. A 143A 2007 2390 2396
63. F. Gok, I. Chefetz, M. Indelman, M. Kocaoglu, and E. Sprecher Newly discovered mutations in the GALNT3 gene causing autosomal recessive hyperostosis-hyperphosphatemia syndrome Acta Orthop. 80 2009 131 134
64. S. Ichikawa, V. Guigonis, E.A. Imel, M. Courouble, S. Heissat, J.D. Henley, A.H. Sorenson, B. Petit, A. Lienhardt, and M.J. Econs Novel GALNT3 mutations causing hyperostosis-hyperphosphatemia syndrome result in low intact fibroblast growth factor 23 concentrations J. Clin. Endocrinol. Metab. 92 2007 1943 1947
65. L. Joseph, S.N. Hing, N. Presneau, P. O'Donnell, T. Diss, B.D. Idowu, S. Joseph, A.M. Flanagan, and D. Delaney Familial tumoral calcinosis and hyperostosis-hyperphosphataemia syndrome are different manifestations of the same disease: novel missense mutations in GALNT3 Skeletal Radiol. 39 2010 63 68
66. A. Laleye, M.J. Alao, G. Gbessi, M. Adjagba, M. Marche, I. Coupry, I. Redonnet-Vernhet, S. Lepreux, B. Ayivi, R.B. Darboux, D. Lacombe, and B. Arveiler Tumoral calcinosis due to GALNT3 C.516-2A>T mutation in a black African family Genet. Couns. 19 2008 183 192
67. H. Olauson, T. Krajisnik, C. Larsson, B. Lindberg, and T.E. Larsson A novel missense mutation in GALNT3 causing hyperostosis-hyperphosphataemia syndrome Eur. J. Endocrinol. 158 2008 929 934
68. P. Specktor, J.G. Cooper, M. Indelman, and E. Sprecher Hyperphosphatemic familial tumoral calcinosis caused by a mutation in GALNT3 in a European kindred J. Hum. Genet. 51 2006 487 490
69. S. Ichikawa, E.A. Imel, M.L. Kreiter, X. Yu, D.S. Mackenzie, A.H. Sorenson, R. Goetz, M. Mohammadi, K.E. White, and M.J. Econs A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis J. Clin. Invest. 117 2007 2684 2691
70. A. Benet-Pages, P. Orlik, T.M. Strom, and B. Lorenz-Depiereux An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia Hum. Mol. Genet. 14 2005 385 390
71. T. Larsson, S.I. Davis, H.J. Garringer, S.D. Mooney, M.S. Draman, M.J. Cullen, and K.E. White Fibroblast growth factor-23 mutants causing familial tumoral calcinosis are differentially processed Endocrinology 146 2005 3883 3891
72. A. Benet-Pages, B. Lorenz-Depiereux, H. Zischka, K.E. White, M.J. Econs, and T.M. Strom FGF23 is processed by proprotein convertases but not by PHEX Bone 35 2004 455 462
73. T.E. Larsson FGF23 beyond mineral metabolism: a bridge to cardiovascular disease Clin. J. Am. Soc. Nephrol. 6 2011 2735 2737
74. R. Goetz, Y. Nakada, M.C. Hu, H. Kurosu, L. Wang, T. Nakatani, M. Shi, A.V. Eliseenkova, M.S. Razzaque, O.W. Moe, M. Kuro-o, and M. Mohammadi Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation Proc. Natl. Acad. Sci. U.S.A. 107 2010 407 412
75. ADHR Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23 Nat. Genet. 26 2000 345 348
76. S. Kathiresan, O. Melander, C. Guiducci, A. Surti, N.P. Burtt, M.J. Rieder, G.M. Cooper, C. Roos, B.F. Voight, A.S. Havulinna, B. Wahlstrand, T. Hedner, D. Corella, E.S. Tai, J.M. Ordovas, G. Berglund, E. Vartiainen, P. Jousilahti, B. Hedblad, M.R. Taskinen, C. Newton-Cheh, V. Salomaa, L. Peltonen, L. Groop, D.M. Altshuler, and M. Orho-Melander Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans Nat. Genet. 40 2008 189 197
77. C.J. Willer, S. Sanna, A.U. Jackson, A. Scuteri, L.L. Bonnycastle, R. Clarke, S.C. Heath, N.J. Timpson, S.S. Najjar, H.M. Stringham, J. Strait, W.L. Duren, A. Maschio, F. Busonero, A. Mulas, G. Albai, A.J. Swift, M.A. Morken, N. Narisu, D. Bennett, S. Parish, H. Shen, P. Galan, P. Meneton, S. Hercberg, D. Zelenika, W.M. Chen, Y. Li, L.J. Scott, P.A. Scheet, J. Sundvall, R.M. Watanabe, R. Nagaraja, S. Ebrahim, D.A. Lawlor, Y. Ben-Shlomo, G. Davey-Smith, A.R. Shuldiner, R. Collins, R.N. Bergman, M. Uda, J. Tuomilehto, A. Cao, F.S. Collins, E. Lakatta, G.M. Lathrop, M. Boehnke, D. Schlessinger, K.L. Mohlke, and G.R. Abecasis Newly identified loci that influence lipid concentrations and risk of coronary artery disease Nat. Genet. 40 2008 161 169
78. T.M. Teslovich, K. Musunuru, A.V. Smith, A.C. Edmondson, I.M. Stylianou, M. Koseki, J.P. Pirruccello, S. Ripatti, D.I. Chasman, C.J. Willer, C.T. Johansen, S.W. Fouchier, A. Isaacs, G.M. Peloso, M. Barbalic, S.L. Ricketts, J.C. Bis, Y.S. Aulchenko, G. Thorleifsson, M.F. Feitosa, J. Chambers, M. Orho-Melander, O. Melander, T. Johnson, X. Li, X. Guo, M. Li, Y. Shin Cho, M. Jin Go, Y. Jin Kim, J.Y. Lee, T. Park, K. Kim, X. Sim, R. Twee-Hee Ong, D.C. Croteau-Chonka, L.A. Lange, J.D. Smith, K. Song, J. Hua Zhao, X. Yuan, J. Luan, C. Lamina, A. Ziegler, W. Zhang, R.Y. Zee, A.F. Wright, J.C. Witteman, J.F. Wilson, G. Willemsen, H.E. Wichmann, J.B. Whitfield, D.M. Waterworth, N.J. Wareham, G. Waeber, P. Vollenweider, B.F. Voight, V. Vitart, A.G. Uitterlinden, M. Uda, J. Tuomilehto, J.R. Thompson, T. Tanaka, I. Surakka, H.M. Stringham, T.D. Spector, N. Soranzo, J.H. Smit, J. Sinisalo, K. Silander, E.J. Sijbrands, A. Scuteri, J. Scott, D. Schlessinger, S. Sanna, V. Salomaa, J. Saharinen, C. Sabatti, A. Ruokonen, I. Rudan, L.M. Rose, R. Roberts, M. Rieder, B.M. Psaty, P.P. Pramstaller, I. Pichler, M. Perola, B.W. Penninx, N.L. Pedersen, C. Pattaro, A.N. Parker, G. Pare, B.A. Oostra, C.J. O'Donnell, M.S. Nieminen, D.A. Nickerson, G.W. Montgomery, T. Meitinger, R. McPherson, M.I. McCarthy, W. McArdle, D. Masson, N.G. Martin, F. Marroni, M. Mangino, P.K. Magnusson, G. Lucas, R. Luben, R.J. Loos, M.L. Lokki, G. Lettre, C. Langenberg, L.J. Launer, E.G. Lakatta, R. Laaksonen, K.O. Kyvik, F. Kronenberg, I.R. Konig, K.T. Khaw, J. Kaprio, L.M. Kaplan, A. Johansson, M.R. Jarvelin, A.C. Janssens, E. Ingelsson, W. Igl, G. Kees Hovingh, J.J. Hottenga, A. Hofman, A.A. Hicks, C. Hengstenberg, I.M. Heid, C. Hayward, A.S. Havulinna, N.D. Hastie, T.B. Harris, T. Haritunians, A.S. Hall, U. Gyllensten, C. Guiducci, L.C. Groop, E. Gonzalez, C. Gieger, N.B. Freimer, L. Ferrucci, J. Erdmann, P. Elliott, K.G. Ejebe, A. Doring, A.F. Dominiczak, S. Demissie, P. Deloukas, E.J. de Geus, U. de Faire, G. Crawford, F.S. Collins, Y.D. Chen, M.J. Caulfield, H. Campbell, N.P. Burtt, L.L. Bonnycastle, D.I. Boomsma, S.M. Boekholdt, R.N. Bergman, I. Barroso, S. Bandinelli, C.M. Ballantyne, T.L. Assimes, T. Quertermous, D. Altshuler, M. Seielstad, T.Y. Wong, E.S. Tai, A.B. Feranil, C.W. Kuzawa, L.S. Adair, H.A. Taylor Jr., I.B. Borecki, S.B. Gabriel, J.G. Wilson, H. Holm, U. Thorsteinsdottir, V. Gudnason, R.M. Krauss, K.L. Mohlke, J.M. Ordovas, P.B. Munroe, J.S. Kooner, A.R. Tall, R.A. Hegele, J.J. Kastelein, E.E. Schadt, J.I. Rotter, E. Boerwinkle, D.P. Strachan, V. Mooser, K. Stefansson, M.P. Reilly, N.J. Samani, H. Schunkert, L.A. Cupples, M.S. Sandhu, P.M. Ridker, D.J. Rader, C.M. van Duijn, L. Peltonen, G.R. Abecasis, M. Boehnke, and S. Kathiresan Biological, clinical and population relevance of 95 loci for blood lipids Nature 466 2010 707 713
79. K.T. Schjoldager, S.Y. Vakhrushev, Y. Kong, C. Steentoft, A.S. Nudelman, N.B. Pedersen, H.H. Wandall, U. Mandel, E.P. Bennett, S.B. Levery, and H. Clausen Probing isoform-specific functions of polypeptide GalNAc-transferases using zinc finger nuclease glycoengineered SimpleCells Proc. Natl. Acad. Sci. U.S.A. 109 25 Jun. 19 2012 9893 9898
80. W. Jin, X. Wang, J.S. Millar, T. Quertermous, G.H. Rothblat, J.M. Glick, and D.J. Rader Hepatic proprotein convertases modulate HDL metabolism Cell Metab. 6 2007 129 136
81. M. Ono, T. Shimizugawa, M. Shimamura, K. Yoshida, C. Noji-Sakikawa, Y. Ando, R. Koishi, and H. Furukawa Protein region important for regulation of lipid metabolism in angiopoietin-like 3 (ANGPTL3): ANGPTL3 is cleaved and activated in vivo J. Biol. Chem. 278 2003 41804 41809
82. J. Liu, H. Afroza, D.J. Rader, and W. Jin Angiopoietin-like protein 3 inhibits lipoprotein lipase activity through enhancing its cleavage by proprotein convertases J. Biol. Chem. 285 2010 27561 27570
83. T. Shimizugawa, M. Ono, M. Shimamura, K. Yoshida, Y. Ando, R. Koishi, K. Ueda, T. Inaba, H. Minekura, T. Kohama, and H. Furukawa ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase J. Biol. Chem. 277 2002 33742 33748
84. K. Nakajima, J. Kobayashi, H. Mabuchi, T. Nakano, Y. Tokita, T. Nagamine, S. Imamura, M. Ai, S. Otokozawa, and E.F. Schaefer Association of angiopoietin-like protein 3 with hepatic triglyceride lipase and lipoprotein lipase activities in human plasma Ann. Clin. Biochem. 47 2010 423 431
85. S. Henrich, A. Cameron, G.P. Bourenkov, R. Kiefersauer, R. Huber, I. Lindberg, W. Bode, and M.E. Than The crystal structure of the proprotein processing proteinase furin explains its stringent specificity Nat. Struct. Biol. 10 2003 520 526
86. S. Henrich, I. Lindberg, W. Bode, and M.E. Than Proprotein convertase models based on the crystal structures of furin and kexin: explanation of their specificity J. Mol. Biol. 345 2005 211 227
87. M. Antenos, L. Lei, M. Xu, A. Malipatil, S. Kiesewetter, and T.K. Woodruff Role of PCSK5 expression in mouse ovarian follicle development: identification of the inhibin alpha- and beta-subunits as candidate substrates PLoS One 6 2011 e17348
88. M. Antenos, J. Zhu, N.M. Jetly, and T.K. Woodruff An activin/furin regulatory loop modulates the processing and secretion of inhibin alpha- and betaB-subunit dimers in pituitary gonadotrope cells J. Biol. Chem. 283 2008 33059 33068
89. Y.R. Hsu, E.W. Hsu, V. Katta, D. Brankow, J. Tseng, S. Hu, C.F. Morris, W.C. Kenney, and H.S. Lu Human keratinocyte growth factor recombinantly expressed in Chinese hamster ovary cells: isolation of isoforms and characterization of post-translational modifications Protein Expr. Purif. 12 1998 189 200
90. A. Varshavsky, O. Kessler, S. Abramovitch, B. Kigel, S. Zaffryar, G. Akiri, and G. Neufeld Semaphorin-3B is an angiogenesis inhibitor that is inactivated by furin-like pro-protein convertases Cancer Res. 68 2008 6922 6931
91. R.D. Sege, K. Kozarsky, D.L. Nelson, and M. Krieger Expression and regulation of human low-density lipoprotein receptors in Chinese hamster ovary cells Nature 307 1984 742 745
92. D.M. Kingsley, and M. Krieger Receptor-mediated endocytosis of low density lipoprotein: somatic cell mutants define multiple genes required for expression of surface-receptor activity Proc. Natl. Acad. Sci. U.S.A. 81 1984 5454 5458
93. D.M. Kingsley, K.F. Kozarsky, L. Hobbie, and M. Krieger Reversible defects in O-linked glycosylation and LDL receptor expression in a UDP-Gal/UDP-GalNAc 4-epimerase deficient mutant Cell 44 1986 749 759
94. K. Kozarsky, D. Kingsley, and M. Krieger Use of a mutant cell line to study the kinetics and function of O-linked glycosylation of low density lipoprotein receptors Proc. Natl. Acad. Sci. U.S.A. 85 1988 4335 4339
95. P. May, H.H. Bock, J. Nimpf, and J. Herz Differential glycosylation regulates processing of lipoprotein receptors by gamma-secretase J. Biol. Chem. 278 2003 37386 37392
96. J. Magrane, R.P. Casaroli-Marano, M. Reina, M. Gafvels, and S. Vilaro The role of O-linked sugars in determining the very low density lipoprotein receptor stability or release from the cell FEBS Lett. 451 1999 56 62
97. J.A. Eldering, J. Grunberg, D. Hahn, H.J. Croes, J.A. Fransen, and E.E. Sterchi Polarised expression of human intestinal N-benzoyl-l-tyrosyl-p- aminobenzoic acid hydrolase (human meprin) alpha and beta subunits in Madin-Darby canine kidney cells Eur. J. Biochem. 247 1997 920 932
98. B. Leuenberger, D. Hahn, A. Pischitzis, M.K. Hansen, and E.E. Sterchi Human meprin beta: O-linked glycans in the intervening region of the type I membrane protein protect the C-terminal region from proteolytic cleavage and diminish its secretion Biochem. J. 369 2003 659 665
99. D. Hahn, A. Pischitzis, S. Roesmann, M.K. Hansen, B. Leuenberger, U. Luginbuehl, and E.E. Sterchi Phorbol 12-myristate 13-acetate-induced ectodomain shedding and phosphorylation of the human meprinbeta metalloprotease J. Biol. Chem. 278 2003 42829 42839
100. R.A. Black, C.T. Rauch, C.J. Kozlosky, J.J. Peschon, J.L. Slack, M.F. Wolfson, B.J. Castner, K.L. Stocking, P. Reddy, S. Srinivasan, N. Nelson, N. Boiani, K.A. Schooley, M. Gerhart, R. Davis, J.N. Fitzner, R.S. Johnson, R.J. Paxton, C.J. March, and D.P. Cerretti A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells Nature 385 1997 729 733
101. M.L. Moss, S.L. Jin, M.E. Milla, D.M. Bickett, W. Burkhart, H.L. Carter, W.J. Chen, W.C. Clay, J.R. Didsbury, D. Hassler, C.R. Hoffman, T.A. Kost, M.H. Lambert, M.A. Leesnitzer, P. McCauley, G. McGeehan, J. Mitchell, M. Moyer, G. Pahel, W. Rocque, L.K. Overton, F. Schoenen, T. Seaton, J.L. Su, and J.D. Becherer Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha Nature 385 1997 733 736
102. R. Takakura-Yamamoto, S. Yamamoto, S. Fukuda, and M. Kurimoto O-glycosylated species of natural human tumor-necrosis factor-alpha Eur. J. Biochem. 235 1996 431 437
103. A.E. Hakalahti, M.M. Vierimaa, M.K. Lilja, E.P. Kumpula, J.T. Tuusa, and U.E. Petaja-Repo Human beta1-adrenergic receptor is subject to constitutive and regulated N-terminal cleavage J. Biol. Chem. 285 2010 28850 28861
104. N. Bannert, S. Craig, M. Farzan, D. Sogah, N.V. Santo, H. Choe, and J. Sodroski Sialylated O-glycans and sulfated tyrosines in the NH2-terminal domain of CC chemokine receptor 5 contribute to high affinity binding of chemokines J. Exp. Med. 194 2001 1661 1673
105. H. Sadeghi, and M. Birnbaumer O-glycosylation of the V2 vasopressin receptor Glycobiology 9 1999 731 737
106. M. Farzan, T. Mirzabekov, P. Kolchinsky, R. Wyatt, M. Cayabyab, N.P. Gerard, C. Gerard, J. Sodroski, and H. Choe Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry Cell 96 1999 667 676
107. U.E. Petaja-Repo, M. Hogue, A. Laperriere, P. Walker, and M. Bouvier Export from the endoplasmic reticulum represents the limiting step in the maturation and cell surface expression of the human delta opioid receptor J. Biol. Chem. 275 2000 13727 13736
108. J.G. Li, C. Chen, and L.Y. Liu-Chen N-glycosylation of the human kappa opioid receptor enhances its stability but slows its trafficking along the biosynthesis pathway Biochemistry 46 2007 10960 10970
109. S. Michineau, F. Alhenc-Gelas, and R.M. Rajerison Human bradykinin B2 receptor sialylation and N-glycosylation participate with disulfide bonding in surface receptor dimerization Biochemistry 45 2006 2699 2707
110. E.B. Maryon, S.A. Molloy, and J.H. Kaplan O-linked glycosylation at threonine 27 protects the copper transporter hCTR1 from proteolytic cleavage in mammalian cells J. Biol. Chem. 282 2007 20376 20387
111. E.B. Maryon, J. Zhang, J.W. Jellison, and J.H. Kaplan Human copper transporter 1 lacking O-linked glycosylation is proteolytically cleaved in a Rab9-positive endosomal compartment J. Biol. Chem. 284 2009 28104 28114
112. S. Kitazume, Y. Tachida, M. Kato, Y. Yamaguchi, T. Honda, Y. Hashimoto, Y. Wada, T. Saito, N. Iwata, T. Saido, and N. Taniguchi Brain endothelial cells produce amyloid beta from amyloid precursor protein 770 and preferentially secrete the O-glycosylated form J. Biol. Chem. 285 2010 40097 40103
113. B.S. Glick, and V. Malhotra The curious status of the Golgi apparatus Cell 95 1998 883 889
114. D.J. Gill, J. Chia, J. Senewiratne, and F. Bard Regulation of O-glycosylation through Golgi-to-ER relocation of initiation enzymes J. Cell Biol. 189 2010 843 858
115. B. Storrie, and T. Nilsson The Golgi apparatus: balancing new with old Traffic 3 2002 521 529
116. E.T. Shifley, and S.E. Cole Lunatic fringe protein processing by proprotein convertases may contribute to the short protein half-life in the segmentation clock Biochim. Biophys. Acta 1783 2008 2384 2390
117. A.V. Woodard-Grice, A.C. McBrayer, J.K. Wakefield, Y. Zhuo, and S.L. Bellis Proteolytic shedding of ST6Gal-I by BACE1 regulates the glycosylation and function of alpha4beta1 integrins J. Biol. Chem. 283 2008 26364 26373
118. Y.P. Yuan, J. Schultz, M. Mlodzik, and P. Bork Secreted fringe-like signaling molecules may be glycosyltransferases Cell 88 1997 9 11
119. K. Bruckner, L. Perez, H. Clausen, and S. Cohen Glycosyltransferase activity of Fringe modulates Notch-Delta interactions Nature 406 2000 411 415
120. I. Chefetz, K. Kohno, H. Izumi, J. Uitto, G. Richard, and E. Sprecher GALNT3, a gene associated with hyperphosphatemic familial tumoral calcinosis, is transcriptionally regulated by extracellular phosphate and modulates matrix metalloproteinase activity Biochim. Biophys. Acta 1792 2009 61 67
121. S. Kim, W. Huang, E.P. Mottillo, A. Sohail, Y.A. Ham, M.K. Conley-Lacomb, C.J. Kim, G. Tzivion, H.R. Kim, S. Wang, Y.Q. Chen, and R. Fridman Posttranslational regulation of membrane type 1-matrix metalloproteinase (MT1-MMP) in mouse PTEN null prostate cancer cells: enhanced surface expression and differential O-glycosylation of MT1-MMP Biochim. Biophys. Acta 1803 2010 1287 1297
122. S. Rottger, J. White, H.H. Wandall, J.C. Olivo, A. Stark, E.P. Bennett, C. Whitehouse, E.G. Berger, H. Clausen, and T. Nilsson Localization of three human polypeptide GalNAc-transferases in HeLa cells suggests initiation of O-linked glycosylation throughout the Golgi apparatus J. Cell Sci. 111 Pt. 1 1998 45 60
123. D.J. Gill, H. Clausen, and F. Bard Location, location, location: new insights into O-GalNAc protein glycosylation Trends Cell Biol. 21 2011 149 158
124. H. Hassan, C.A. Reis, E.P. Bennett, E. Mirgorodskaya, P. Roepstorff, M.A. Hollingsworth, J. Burchell, J. Taylor-Papadimitriou, and H. Clausen The lectin domain of UDP-N-acetyl-d-galactosamine: polypeptide N- acetylgalactosaminyltransferase-T4 directs its glycopeptide specificities J. Biol. Chem. 275 2000 38197 38205
125. H.H. Wandall, F. Irazoqui, M.A. Tarp, E.P. Bennett, U. Mandel, H. Takeuchi, K. Kato, T. Irimura, G. Suryanarayanan, M.A. Hollingsworth, and H. Clausen The lectin domains of polypeptide GalNAc-transferases exhibit carbohydrate-binding specificity for GalNAc: lectin binding to GalNAc-glycopeptide substrates is required for high density GalNAc-O- glycosylation Glycobiology 17 2007 374 387
126. R. Harrison, P.G. Hitchen, M. Panico, H.R. Morris, D. Mekheil, R.J. Pleass, A. Dell, J.E. Hewitt, and S.M. Haslam Glycoproteomic characterisation of recombinant mouse alpha-dystroglycan Glycobiology 22 5 May 2012 662 675
127. J. Nilsson, G. Larson, and A. Grahn Characterization of site-specific O-glycan structures within the mucin-like domain of alpha-dystroglycan from human skeletal muscle Glycobiology 20 2010 1160 1169
128. C. Lorenz, S. Strahl-Bolsinger, and J.F. Ernst Specific in vitro O-glycosylation of human granulocyte-macrophage colony-stimulating-factor- derived peptides by O-glycosyltransferases of yeast and rat liver cells Eur. J. Biochem. 205 1992 1163 1167
129. S.H. Stalnaker, S. Hashmi, J.M. Lim, K. Aoki, M. Porterfield, G. Gutierrez-Sanchez, J. Wheeler, J.M. Ervasti, C. Bergmann, M. Tiemeyer, and L. Wells Site mapping and characterization of O-glycan structures on alpha-dystroglycan isolated from rabbit skeletal muscle J. Biol. Chem. 285 2010 24882 24891
130. K.W. Moremen, M. Tiemeyer, and A.V. Nairn Vertebrate protein glycosylation: diversity, synthesis and function Nat. Rev. Mol. Cell Biol. 13 2012 448 462
131. J.P. Briand, S.P. Andrews Jr., E. Cahill, N.A. Conway, and J.D. Young Investigation of the requirements for O-glycosylation by bovine submaxillary gland UDP-N-acetylgalactosamine:polypeptide N-acetylgalactosamine transferase using synthetic peptide substrates J. Biol. Chem. 256 1981 12205 12207
132. A.P. Elhammer, R.A. Poorman, E. Brown, L.L. Maggiora, J.G. Hoogerheide, and F.J. Kezdy The specificity of UDP-GalNAc:polypeptide N- acetylgalactosaminyltransferase as inferred from a database of in vivo substrates and from the in vitro glycosylation of proteins and peptides J. Biol. Chem. 268 1993 10029 10038
133. B. O'Connell, L.A. Tabak, and N. Ramasubbu The influence of flanking sequences on O-glycosylation Biochem. Biophys. Res. Commun. 180 1991 1024 1030
134. I.B. Wilson, Y. Gavel, and G. von Heijne Amino acid distributions around O-linked glycosylation sites Biochem. J. 275 Pt. 2 1991 529 534
135. B.C. O'Connell, F.K. Hagen, and L.A. Tabak The influence of flanking sequence on the O-glycosylation of threonine in vitro J. Biol. Chem. 267 1992 25010 25018
136. K. Nehrke, F.K. Hagen, and L.A. Tabak Charge distribution of flanking amino acids influences O-glycan acquisition in vivo J. Biol. Chem. 271 1996 7061 7065
137. E.P. Bennett, H. Hassan, and H. Clausen cDNA cloning and expression of a novel human UDP-N-acetyl-alpha-d-galactosamine. Polypeptide N- acetylgalactosaminyltransferase, GalNAc-t3 J. Biol. Chem. 271 1996 17006 17012
138. E.P. Bennett, H. Hassan, U. Mandel, E. Mirgorodskaya, P. Roepstorff, J. Burchell, J. Taylor-Papadimitriou, M.A. Hollingsworth, G. Merkx, A.G. van Kessel, H. Eiberg, R. Steffensen, and H. Clausen Cloning of a human UDP-N-acetyl-alpha-d-galactosamine:polypeptide N-acetylgalactosaminyltransferase that complements other GalNAc-transferases in complete O-glycosylation of the MUC1 tandem repeat J. Biol. Chem. 273 1998 30472 30481
139. L. Cheng, K. Tachibana, H. Iwasaki, A. Kameyama, Y. Zhang, T. Kubota, T. Hiruma, T. Kudo, J.M. Guo, and H. Narimatsu Characterization of a novel human UDP-GalNAc transferase, pp-GalNAc-T15 FEBS Lett. 566 2004 17 24
140. L. Cheng, K. Tachibana, Y. Zhang, J. Guo, K. Kahori Tachibana, A. Kameyama, H. Wang, T. Hiruma, H. Iwasaki, A. Togayachi, T. Kudo, and H. Narimatsu Characterization of a novel human UDP-GalNAc transferase, pp-GalNAc-T10 FEBS Lett. 531 2002 115 121
141. F.K. Hagen, B. Van Wuyckhuyse, and L.A. Tabak Purification, cloning, and expression of a bovine UDP-GalNAc:polypeptide N-acetyl-galactosaminyltransferase J. Biol. Chem. 268 1993 18960 18965
142. X. Li, J. Wang, W. Li, Y. Xu, D. Shao, Y. Xie, W. Xie, T. Kubota, H. Narimatsu, and Y. Zhang Characterization of ppGalNAc-T18, a member of the vertebrate-specific Y subfamily of UDP-N-acetyl-alpha-d-galactosamine: polypeptide N-acetylgalactosaminyltransferases Glycobiology 22 2012 602 615
143. K.G. Ten Hagen, G.S. Bedi, D. Tetaert, P.D. Kingsley, F.K. Hagen, M.M. Balys, T.M. Beres, P. Degand, and L.A. Tabak Cloning and characterization of a ninth member of the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase family, ppGaNTase-T9 J. Biol. Chem. 276 2001 17395 17404
144. H. Wang, K. Tachibana, Y. Zhang, H. Iwasaki, A. Kameyama, L. Cheng, J. Guo, T. Hiruma, A. Togayachi, T. Kudo, N. Kikuchi, and H. Narimatsu Cloning and characterization of a novel UDP-GalNAc:polypeptide N- acetylgalactosaminyltransferase, pp-GalNAc-T14 Biochem. Biophys. Res. Commun. 300 2003 738 744
145. Y. Zhang, H. Iwasaki, H. Wang, T. Kudo, T.B. Kalka, T. Hennet, T. Kubota, L. Cheng, N. Inaba, M. Gotoh, A. Togayachi, J. Guo, H. Hisatomi, K. Nakajima, S. Nishihara, M. Nakamura, J.D. Marth, and H. Narimatsu Cloning and characterization of a new human UDP-N-acetyl-alpha-d-galactosamine:polypeptide N-acetylgalactosaminyltransferase, designated pp-GalNAc-T13, that is specifically expressed in neurons and synthesizes GalNAc alpha-serine/threonine antigen J. Biol. Chem. 278 2003 573 584
146. T.A. Gerken, K.G. Ten Hagen, and O. Jamison Conservation of peptide acceptor preferences between Drosophila and mammalian polypeptide-GalNAc transferase ortholog pairs Glycobiology 18 2008 861 870
147. R. Gupta, H. Birch, K. Rapacki, S. Brunak, and J.E. Hansen O-GLYCBASE version 4.0: a revised database of O-glycosylated proteins Nucleic Acids Res. 27 1999 370 372
148. J.E. Hansen, O. Lund, N. Tolstrup, A.A. Gooley, K.L. Williams, and S. Brunak NetOglyc: prediction of mucin type O-glycosylation sites based on sequence context and surface accessibility Glycoconj. J. 15 1998 115 130
149. K. Julenius, A. Molgaard, R. Gupta, and S. Brunak Prediction, conservation analysis, and structural characterization of mammalian mucin-type O-glycosylation sites Glycobiology 15 2005 153 164
150. J. Jaeken Congenital disorders of glycosylation Ann. N. Y. Acad. Sci. 1214 2010 190 198
151. P.T. Martin Congenital muscular dystrophies involving the O-mannose pathway Curr. Mol. Med. 7 2007 417 425
152. M. Gotte, and H. Kresse Defective glycosaminoglycan substitution of decorin in a patient with progeroid syndrome is a direct consequence of two point mutations in the galactosyltransferase I (beta4GalT-7) gene Biochem. Genet. 43 2005 65 77
153. T. Ju, and R.D. Cummings Protein glycosylation: chaperone mutation in Tn syndrome Nature 437 2005 1252
154. J.B. Lowe, and J.D. Marth A genetic approach to mammalian glycan function Annu. Rev. Biochem. 72 2003 643 691
155. K.G. Ten Hagen, T.A. Fritz, and L.A. Tabak All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases Glycobiology 13 2003 1R 16R
156. M. Tenno, K. Ohtsubo, F.K. Hagen, D. Ditto, A. Zarbock, P. Schaerli, U.H. von Andrian, K. Ley, D. Le, L.A. Tabak, and J.D. Marth Initiation of protein O glycosylation by the polypeptide GalNAcT-1 in vascular biology and humoral immunity Mol. Cell. Biol. 27 2007 8783 8796
157. S. Ichikawa, A.H. Sorenson, A.M. Austin, D.S. Mackenzie, T.A. Fritz, A. Moh, S.L. Hui, and M.J. Econs Ablation of the Galnt3 gene leads to low-circulating intact fibroblast growth factor 23 (Fgf23) concentrations and hyperphosphatemia despite increased Fgf23 expression Endocrinology 150 2009 2543 2550
158. E. Rajpert-De Meyts, S.N. Poll, I. Goukasian, C. Jeanneau, A.S. Herlihy, E.P. Bennett, N.E. Skakkebaek, H. Clausen, A. Giwercman, and U. Mandel Changes in the profile of simple mucin-type O-glycans and polypeptide GalNAc-transferases in human testis and testicular neoplasms are associated with germ cell maturation and tumour differentiation Virchows Arch. 451 2007 805 814
159. C. Esapa, R. Head, E. Chan, M. Crane, M. Cheeseman, T. Hough, E. McNally, A. Carr, G. Thomas, M. Brwon, P. Croucher, S. Brown, R. Cox, and R. Thakker A mouse with a Trp589Arg mutation in N-acetylgalactosaminyltransferase 3 (Galnt3) provides a model for familial tumoral calcinosis Endocr. Abstr. 19 2009
160. E.L. Duncan, P. Danoy, J.P. Kemp, P.J. Leo, E. McCloskey, G.C. Nicholson, R. Eastell, R.L. Prince, J.A. Eisman, G. Jones, P.N. Sambrook, I.R. Reid, E.M. Dennison, J. Wark, J.B. Richards, A.G. Uitterlinden, T.D. Spector, C. Esapa, R.D. Cox, S.D. Brown, R.V. Thakker, K.A. Addison, L.A. Bradbury, J.R. Center, C. Cooper, C. Cremin, K. Estrada, D. Felsenberg, C.C. Gluer, J. Hadler, M.J. Henry, A. Hofman, M.A. Kotowicz, J. Makovey, S.C. Nguyen, T.V. Nguyen, J.A. Pasco, K. Pryce, D.M. Reid, F. Rivadeneira, C. Roux, K. Stefansson, U. Styrkarsdottir, G. Thorleifsson, R. Tichawangana, D.M. Evans, and M.A. Brown Genome-wide association study using extreme truncate selection identifies novel genes affecting bone mineral density and fracture risk PLoS Genet. 7 2011 e1001372
161. K.D. Carmichael, J.A. Bynum, and E.B. Evans Familial tumoral calcinosis: a forty-year follow-up on one family J. Bone Joint Surg. Am. 91 2009 664 671
162. T. Schwientek, E.P. Bennett, C. Flores, J. Thacker, M. Hollmann, C.A. Reis, J. Behrens, U. Mandel, B. Keck, M.A. Schafer, K. Haselmann, R. Zubarev, P. Roepstorff, J.M. Burchell, J. Taylor-Papadimitriou, M.A. Hollingsworth, and H. Clausen Functional conservation of subfamilies of putative UDP-N- acetylgalactosamine:polypeptide N-acetylgalactosaminyltransferases in Drosophila, Caenorhabditis elegans, and mammals. One subfamily composed of l(2)35Aa is essential in Drosophila J. Biol. Chem. 277 2002 22623 22638
163. C. Flores, and W. Engels Microsatellite instability in Drosophila spellchecker1 (MutS homolog) mutants Proc. Natl. Acad. Sci. U.S.A. 96 1999 2964 2969
164. D.T. Tran, L. Zhang, Y. Zhang, E. Tian, L. Earl, and K.G. Ten Hagen Additional members of the polypeptide GalNAc transferase family are essential for viability in Drosophila J. Biol. Chem. 287 8 Feb. 17 2012 5243 5252
165. E.P. Bennett, Y.W. Chen, T. Schwientek, U. Mandel, K.B. Schjoldager, S.M. Cohen, and H. Clausen Rescue of Drosophila melanogaster l(2)35Aa lethality is only mediated by polypeptide GalNAc-transferase pgant35A, but not by the evolutionary conserved human ortholog GalNAc-transferase-T11 Glycoconj. J. 27 2010 435 444
166. F. Bard, L. Casano, A. Mallabiabarrena, E. Wallace, K. Saito, H. Kitayama, G. Guizzunti, Y. Hu, F. Wendler, R. Dasgupta, N. Perrimon, and V. Malhotra Functional genomics reveals genes involved in protein secretion and Golgi organization Nature 439 2006 604 607
167. L. Zhang, and K.G. Ten Hagen Dissecting the biological role of mucin-type O-glycosylation using RNA interference in Drosophila cell culture J. Biol. Chem. 285 2010 34477 34484
168. H. Wang, A. Spang, M.A. Sullivan, J. Hryhorenko, and F.K. Hagen The terminal phase of cytokinesis in the Caenorhabditis elegans early embryo requires protein glycosylation Mol. Biol. Cell 16 2005 4202 4213
169. A.G. Holleboom, H. Karlsson, R.S. Lin, T.M. Beres, J.A. Sierts, D.S. Herman, E.S. Stroes, J.M. Aerts, J.J. Kastelein, M.M. Motazacker, G.M. Dallinga-Thie, J.H. Levels, A.H. Zwinderman, J.G. Seidman, C.E. Seidman, S. Ljunggren, D.J. Lefeber, E. Morava, R.A. Wevers, T.A. Fritz, L.A. Tabak, M. Lindahl, G.K. Hovingh, and J.A. Kuivenhoven Heterozygosity for a loss-of-function mutation in GALNT2 improves plasma triglyceride clearance in man Cell Metab. 14 2011 811 818
170. C.M. Phelan, Y.Y. Tsai, E.L. Goode, R.A. Vierkant, B.L. Fridley, J. Beesley, X.Q. Chen, P.M. Webb, S. Chanock, D.W. Cramer, K. Moysich, R.P. Edwards, J. Chang-Claude, M. Garcia-Closas, H. Yang, S. Wang-Gohrke, R. Hein, A.C. Green, J. Lissowska, M.E. Carney, G. Lurie, L.R. Wilkens, R.B. Ness, C.L. Pearce, A.H. Wu, D.J. Van Den Berg, D.O. Stram, K.L. Terry, D.C. Whiteman, A.S. Whittemore, R.A. DiCioccio, V. McGuire, J.A. Doherty, M.A. Rossing, H. Anton-Culver, A. Ziogas, C. Hogdall, E. Hogdall, S. Kruger Kjaer, J. Blaakaer, L. Quaye, S.J. Ramus, I. Jacobs, H. Song, P.D. Pharoah, E.S. Iversen, J.R. Marks, M.C. Pike, S.A. Gayther, J.M. Cunningham, M.T. Goodman, J.M. Schildkraut, G. Chenevix-Trench, A. Berchuck, and T.A. Sellers Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium Cancer Epidemiol. Biomarkers Prev. 19 2010 600 604
171. T.A. Sellers, Y. Huang, J. Cunningham, E.L. Goode, R. Sutphen, R.A. Vierkant, L.E. Kelemen, Z.S. Fredericksen, M. Liebow, V.S. Pankratz, L.C. Hartmann, J. Myer, E.S. Iversen Jr., J.M. Schildkraut, and C. Phelan Association of single nucleotide polymorphisms in glycosylation genes with risk of epithelial ovarian cancer Cancer Epidemiol. Biomarkers Prev. 17 2008 397 404
172. M.C. Ng, J.M. Hester, M.R. Wing, J. Li, J. Xu, P.J. Hicks, B.H. Roh, L. Lu, J. Divers, C.D. Langefeld, B.I. Freedman, N.D. Palmer, and D.W. Bowden Genome-wide association of BMI in African Americans Obesity (Silver Spring) 20 3 Mar. 2012 622 627
173. K.A. Fakhro, M. Choi, S.M. Ware, J.W. Belmont, J.A. Towbin, R.P. Lifton, M.K. Khokha, and M. Brueckner Rare copy number variations in congenital heart disease patients identify unique genes in left-right patterning Proc. Natl. Acad. Sci. U.S.A. 108 2011 2915 2920
174. J.M. Guo, H.L. Chen, G.M. Wang, Y.K. Zhang, and H. Narimatsu Expression of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-12 in gastric and colonic cancer cell lines and in human colorectal cancer Oncology 67 2004 271 276
175. E. Clarke, R.C. Green, J.S. Green, K. Mahoney, P.S. Parfrey, H.B. Younghusband, and M.O. Woods Inherited deleterious variants in GALNT12 are associated with CRC susceptibility Hum. Mutat. 33 7 Jul. 2012 1056 1058
176. K. Guda, H. Moinova, J. He, O. Jamison, L. Ravi, L. Natale, J. Lutterbaugh, E. Lawrence, S. Lewis, J.K. Willson, J.B. Lowe, G.L. Wiesner, G. Parmigiani, J. Barnholtz-Sloan, D.W. Dawson, V.E. Velculescu, K.W. Kinzler, N. Papadopoulos, B. Vogelstein, J. Willis, T.A. Gerken, and S.D. Markowitz Inactivating germ-line and somatic mutations in polypeptide N- acetylgalactosaminyltransferase 12 in human colon cancers Proc. Natl. Acad. Sci. U.S.A. 106 2009 12921 12925
177. A.M. O'Halloran, C.C. Patterson, P. Horan, A. Maree, R. Curtin, A. Stanton, P.P. McKeown, and D.C. Shields Genetic polymorphisms in platelet-related proteins and coronary artery disease: investigation of candidate genes, including N-acetylgalactosaminyltransferase 4 (GALNT4) and sulphotransferase 1A1/2 (SULT1A1/2) J. Thromb. Thrombolysis 27 2009 175 184
178. K.W. Wagner, E.A. Punnoose, T. Januario, D.A. Lawrence, R.M. Pitti, K. Lancaster, D. Lee, M. von Goetz, S.F. Yee, K. Totpal, L. Huw, V. Katta, G. Cavet, S.G. Hymowitz, L. Amler, and A. Ashkenazi Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL Nat. Med. 13 2007 1070 1077
179. N. Berois, D. Mazal, L. Ubillos, F. Trajtenberg, A. Nicolas, X. Sastre-Garau, H. Magdelenat, and E. Osinaga UDP-N-acetyl-d-galactosamine: polypeptide N-acetylgalactosaminyltransferase-6 as a new immunohistochemical breast cancer marker J. Histochem. Cytochem. 54 2006 317 328
180. J. Gomes, N.T. Marcos, N. Berois, E. Osinaga, A. Magalhaes, J. Pinto-de-Sousa, R. Almeida, F. Gartner, and C.A. Reis Expression of UDP-N-acetyl-d-galactosamine: polypeptide N-acetylgalactosaminyltransferase-6 in gastric mucosa, intestinal metaplasia, and gastric carcinoma J. Histochem. Cytochem. 57 2009 79 86
181. Z. Li, S. Yamada, S. Inenaga, T. Imamura, Y. Wu, K.Y. Wang, S. Shimajiri, R. Nakano, H. Izumi, K. Kohno, and Y. Sasaguri Polypeptide N- acetylgalactosaminyltransferase 6 expression in pancreatic cancer is an independent prognostic factor indicating better overall survival Br. J. Cancer 104 2011 1882 1889
182. J.H. Park, T. Katagiri, S. Chung, K. Kijima, and Y. Nakamura Polypeptide N-acetylgalactosaminyltransferase 6 disrupts mammary acinar morphogenesis through O-glycosylation of fibronectin Neoplasia 13 2011 320 326
183. L. Freire-de-Lima, K. Gelfenbeyn, Y. Ding, U. Mandel, H. Clausen, K. Handa, and S.I. Hakomori Involvement of O-glycosylation defining oncofetal fibronectin in epithelial-mesenchymal transition process Proc. Natl. Acad. Sci. U.S.A. 108 2011 17690 17695
184. G. Palmisano, S.E. Lendal, K. Engholm-Keller, R. Leth-Larsen, B.L. Parker, and M.R. Larsen Selective enrichment of sialic acid-containing glycopeptides using titanium dioxide chromatography with analysis by HILIC and mass spectrometry Nat. Protoc. 5 2010 1974 1982
185. Z. Darula, and K.F. Medzihradszky Affinity enrichment and characterization of mucin core-1 type glycopeptides from bovine serum Mol. Cell Proteomics 8 2009 2515 2526
186. Z. Darula, R.J. Chalkley, A. Lynn, P.R. Baker, and K.F. Medzihradszky Improved identification of O-linked glycopeptides from ETD data with optimized scoring for different charge states and cleavage specificities Amino Acids 41 2011 321 328
187. Z. Darula, J. Sherman, and K.F. Medzihradszky How to dig deeper? Improved enrichment methods for mucin core-1 type glycopeptides Mol. Cell Proteomics 11 7 Jul. 2012 O111.016774
188. P.R. Baker, K.F. Medzihradszky, and R.J. Chalkley Improving software performance for peptide electron transfer dissociation data analysis by implementation of charge state- and sequence-dependent scoring Mol. Cell Proteomics 9 2010 1795 1803
189. Y. Wang, T. Ju, X. Ding, B. Xia, W. Wang, L. Xia, M. He, and R.D. Cummings Cosmc is an essential chaperone for correct protein O-glycosylation Proc. Natl. Acad. Sci. U.S.A. 107 2010 9228 9233
190. T. Iwai, T. Kudo, R. Kawamoto, T. Kubota, A. Togayachi, T. Hiruma, T. Okada, T. Kawamoto, K. Morozumi, and H. Narimatsu Core 3 synthase is down-regulated in colon carcinoma and profoundly suppresses the metastatic potential of carcinoma cells Proc. Natl. Acad. Sci. U.S.A. 102 2005 4572 4577
191. T. Ju, G.S. Lanneau, T. Gautam, Y. Wang, B. Xia, S.R. Stowell, M.T. Willard, W. Wang, J.Y. Xia, R.E. Zuna, Z. Laszik, D.M. Benbrook, M.H. Hanigan, and R.D. Cummings Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc Cancer Res. 68 2008 1636 1646
192. S. Wopereis, S. Grunewald, K.M. Huijben, E. Morava, R. Mollicone, B.G. van Engelen, D.J. Lefeber, and R.A. Wevers Transferrin and apolipoprotein C-III isofocusing are complementary in the diagnosis of N- and O-glycan biosynthesis defects Clin. Chem. 53 2007 180 187
193. A. Varki Biological roles of oligosaccharides: all of the theories are correct Glycobiology 3 1993 97 130
194. L.A. Jurado, A. Coloma, and J. Cruces Identification of a human homolog of the Drosophila rotated abdomen gene (POMT1) encoding a putative protein O-mannosyl-transferase, and assignment to human chromosome 9q34.1 Genomics 58 1999 171 180
195. T. Yoshida-Moriguchi, L. Yu, S.H. Stalnaker, S. Davis, S. Kunz, M. Madson, M.B. Oldstone, H. Schachter, L. Wells, and K.P. Campbell O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding Science 327 2010 88 92
196. Y. Wang, L. Shao, S. Shi, R.J. Harris, M.W. Spellman, P. Stanley, and R.S. Haltiwanger Modification of epidermal growth factor-like repeats with O-fucose. Molecular cloning and expression of a novel GDP-fucose protein O-fucosyltransferase J. Biol. Chem. 276 2001 40338 40345
197. B. Schegg, A.J. Hulsmeier, C. Rutschmann, C. Maag, and T. Hennet Core glycosylation of collagen is initiated by two beta(1-O)galactosyltransferases Mol. Cell. Biol. 29 2009 943 952
198. Y. Teng, Q. Liu, J. Ma, F. Liu, Z. Han, Y. Wang, and W. Wang Cloning, expression and characterization of a novel human CAP10-like gene hCLP46 from CD34(+) stem/progenitor cells Gene 371 2006 7 15
199. L.K. Kreppel, M.A. Blomberg, and G.W. Hart Dynamic glycosylation of nuclear and cytosolic proteins. Cloning and characterization of a unique O-GlcNAc transferase with multiple tetratricopeptide repeats J. Biol. Chem. 272 1997 9308 9315
200. K. Akasaka-Manya, H. Manya, and T. Endo Mutations of the POMT1 gene found in patients with Walker-Warburg syndrome lead to a defect of protein O-mannosylation Biochem. Biophys. Res. Commun. 325 2004 75 79
201. E. Condac, R. Silasi-Mansat, S. Kosanke, T. Schoeb, R. Towner, F. Lupu, R.D. Cummings, and M.E. Hinsdale Polycystic disease caused by deficiency in xylosyltransferase 2, an initiating enzyme of glycosaminoglycan biosynthesis Proc. Natl. Acad. Sci. U.S.A. 104 2007 9416 9421
202. M. Faiyaz-Ul-Haque, S.H. Zaidi, M. Al-Ali, M.S. Al-Mureikhi, S. Kennedy, G. Al-Thani, L.C. Tsui, and A.S. Teebi A novel missense mutation in the galactosyltransferase-I (B4GALT7) gene in a family exhibiting facioskeletal anomalies and Ehlers-Danlos syndrome resembling the progeroid type Am. J. Med. Genet. A 128A 2004 39 45
203. R. Fernandez-Valdivia, H. Takeuchi, A. Samarghandi, M. Lopez, J. Leonardi, R.S. Haltiwanger, and H. Jafar-Nejad Regulation of mammalian Notch signaling and embryonic development by the protein O-glucosyltransferase Rumi Development 138 2011 1925 1934
204. S.A. Lesnik Oberstein, M. Kriek, S.J. White, M.E. Kalf, K. Szuhai, J.T. den Dunnen, M.H. Breuning, and R.C. Hennekam Peters Plus syndrome is caused by mutations in B3GALTL, a putative glycosyltransferase Am. J. Hum. Genet. 79 2006 562 566
205. R. Shafi, S.P. Iyer, L.G. Ellies, N. O'Donnell, K.W. Marek, D. Chui, G.W. Hart, and J.D. Marth The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny Proc. Natl. Acad. Sci. U.S.A. 97 2000 5735 5739
206. S. Shi, and P. Stanley Protein O-fucosyltransferase 1 is an essential component of Notch signaling pathways Proc. Natl. Acad. Sci. U.S.A. 100 2003 5234 5239
207. J. van Reeuwijk, M. Janssen, C. van den Elzen, D. Beltran-Valero de Bernabe, P. Sabatelli, L. Merlini, M. Boon, H. Scheffer, M. Brockington, F. Muntoni, M.A. Huynen, A. Verrips, C.A. Walsh, P.G. Barth, H.G. Brunner, and H. van Bokhoven POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome J. Med. Genet. 42 2005 907 912
208. A. Yoshida, K. Kobayashi, H. Manya, K. Taniguchi, H. Kano, M. Mizuno, T. Inazu, H. Mitsuhashi, S. Takahashi, M. Takeuchi, R. Herrmann, V. Straub, B. Talim, T. Voit, H. Topaloglu, T. Toda, and T. Endo Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1 Dev. Cell 1 2001 717 724
209. M. Park, and A.J. Tenner Cell surface expression of C1qRP/CD93 is stabilized by O-glycosylation J. Cell. Physiol. 196 2003 512 522
210. J.A. Marinaro, D.J. Casley, and L.A. Bach O-glycosylation delays the clearance of human IGF-binding protein-6 from the circulation Eur. J. Endocrinol. 142 2000 512 516
211. A.G. Remacle, A.V. Chekanov, V.S. Golubkov, A.Y. Savinov, D.V. Rozanov, and A.Y. Strongin O-glycosylation regulates autolysis of cellular membrane type-1 matrix metalloproteinase (MT1-MMP) J. Biol. Chem. 281 2006 16897 16905
212. E.A. Rutledge, B.J. Root, J.J. Lucas, and C.A. Enns Elimination of the O-linked glycosylation site at Thr 104 results in the generation of a soluble human-transferrin receptor Blood 83 1994 580 586
213. C.G. Voigt, I. Maurer-Fogy, and G.R. Adolf Natural human tumor necrosis factor beta (lymphotoxin). Variable O-glycosylation at Thr7, proteolytic processing, and allelic variation FEBS Lett. 314 1992 85 88